Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma

Soma (Carisoprodol) is N-isopropyl-2 methyl-2-propyl-1,3-propanediol dicarbamate; a commonly prescribed, centrally acting skeletal muscle relaxant. Neuroleptic malignant syndrome (NMS) is a potentially life-threatening adverse effect of antipsychotic agents. Although diagnostic criteria for NMS have...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Gunchan, Parshotam, Gautam L, Garg, Rajneesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009851/
https://www.ncbi.nlm.nih.gov/pubmed/27625493
http://dx.doi.org/10.4103/0970-9185.173346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009851/
https://www.ncbi.nlm.nih.gov/pubmed/27625493
http://dx.doi.org/10.4103/0970-9185.173346

Ejemplares similares